相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Supporting evidence for using biomarkers in the diagnosis of MCI due to AD
Samantha Galluzzi et al.
JOURNAL OF NEUROLOGY (2013)
Alzheimer Mechanisms and Therapeutic Strategies
Yadong Huang et al.
CELL (2012)
Longitudinal analysis of novel Alzheimer's disease proteomic cerebrospinal fluid biomarkers during intravenous immunoglobulin therapy
Gilda Shayan et al.
ELECTROPHORESIS (2012)
A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease
Rashid Deane et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Reducing Available Soluble β-Amyloid Prevents Progression of Cerebral Amyloid Angiopathy in Transgenic Mice
Julia L. Gregory et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2012)
LRP1 in Brain Vascular Smooth Muscle Cells Mediates Local Clearance of Alzheimer's Amyloid-β
Takahisa Kanekiyo et al.
JOURNAL OF NEUROSCIENCE (2012)
The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes
Iryna Benilova et al.
NATURE NEUROSCIENCE (2012)
Low-density lipoprotein receptor-related protein 1: A physiological Aβ homeostatic mechanism with multiple therapeutic opportunities
Abhay P. Sagare et al.
PHARMACOLOGY & THERAPEUTICS (2012)
Withania somnifera reverses Alzheimer's disease pathology by enhancing low-density lipoprotein receptor-related protein in liver
Neha Sehgal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Preventing Alzheimer's Disease
Dennis J. Selkoe
SCIENCE (2012)
Proteolytic Degradation of Amyloid β-Protein
Takaomi Saido et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Current and Emerging Drug Treatment Options for Alzheimerʼs Disease
Nathan Herrmann et al.
DRUGS (2011)
Activation of matrix metalloproteinases following anti-Aβ immunotherapy; implications for microhemorrhage occurrence
Donna M. Wilcock et al.
JOURNAL OF NEUROINFLAMMATION (2011)
Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders
Berislav V. Zlokovic
NATURE REVIEWS NEUROSCIENCE (2011)
Intravenous Immunoglobulins as a Treatment for Alzheimer's Disease Rationale and Current Evidence
Richard Dodel et al.
DRUGS (2010)
Antibody concentrations to A beta 1-42 monomer and soluble oligomers in untreated and antibody-antigen-dissociated intravenous immunoglobulin preparations
Andrea C. Klaver et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2010)
Comparison of Intravenous Immunoglobulins for Naturally Occurring Autoantibodies against Amyloid-beta
Karthikeyan Balakrishnan et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Low-density lipoprotein receptor-related protein-1: a serial clearance homeostatic mechanism controlling Alzheimer's amyloid beta-peptide elimination from the brain
Berislav V. Zlokovic et al.
JOURNAL OF NEUROCHEMISTRY (2010)
Measurement of anti-beta amyloid antibodies in human blood
Paul Szabo et al.
JOURNAL OF NEUROIMMUNOLOGY (2010)
MECHANISMS OF DISEASE Alzheimer's Disease
Henry W. Querfurth et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Decreased Clearance of CNS β-Amyloid in Alzheimer's Disease
Kwasi G. Mawuenyega et al.
SCIENCE (2010)
Burrowing: A sensitive behavioural assay, tested in five species of laboratory rodents
R. M. J. Deacon
BEHAVIOURAL BRAIN RESEARCH (2009)
Clearance of Amyloid-beta Peptide Across the Blood-Brain Barrier: Implication for Therapies in Alzheimer's Disease
R. Deane et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2009)
Testing the Neurovascular Hypothesis of Alzheimer's Disease: LRP-1 Antisense Reduces Blood-Brain Barrier Clearance, Increases Brain Levels of Amyloid-β Protein, and Impairs Cognition
Laura B. Jaeger et al.
JOURNAL OF ALZHEIMERS DISEASE (2009)
SRF and myocardin regulate LRP-mediated amyloid-β clearance in brain vascular cells
Robert D. Bell et al.
NATURE CELL BIOLOGY (2009)
18-Month study of intravenous immunoglobulin for treatment of mild Alzheimer disease
Norman R. Relkin et al.
NEUROBIOLOGY OF AGING (2009)
Neuroprotective natural antibodies to assemblies of amyloidogenic peptides decrease with normal aging and advancing Alzheimer's disease
M. Britschgi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
apoE isoform-specific disruption of amyloid β peptide clearance from mouse brain
Rashid Deane et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration
Zhihui Zhong et al.
NATURE NEUROSCIENCE (2008)
Peripheral transgene expression of plasma gelsolin reduces amyloid in transgenic mouse models of Alzheimer's disease
Aaron C. Hirko et al.
MOLECULAR THERAPY (2007)
Clearance of amyloid-β by circulating lipoprotein receptors
Abhay Sagare et al.
NATURE MEDICINE (2007)
Functional duplication of ligand-binding domains within low-density lipoprotein receptor-related protein for interaction with receptor associated protein, α2-macroglobulin, factor IXa and factor VIII
Alexander B. Meijer et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2007)
Transport pathways for clearance of human Alzheimer's amyloid β-peptide and apolipoproteins E and J in the mouse central nervous system
Robert D. Bell et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2007)
Functional characterization of the brain-to-blood efflux clearance of human amyloid-β peptide (1-40) across the rat blood-brain barrier
Shingo Ito et al.
NEUROSCIENCE RESEARCH (2006)
RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease
John E. Donahue et al.
ACTA NEUROPATHOLOGICA (2006)
Major involvement of low-density lipoprotein receptor-related protein 1 in the clearance of plasma free amyloid β-peptide by the liver
Chihiro Tamaki et al.
PHARMACEUTICAL RESEARCH (2006)
IgG-assisted age-dependent clearance of Alzheimer's amyloid β peptide by the blood-brain barrier neonatal Fc receptor
R Deane et al.
JOURNAL OF NEUROSCIENCE (2005)
Neuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein
OM Andersen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
ABCA1 is required for normal central nervous system ApoE levels and for lipidation of astrocyte-secreted apoE
SE Wahrle et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
LRP/amyloid β-peptide interaction mediates differential brain efflux of Aβ isoforms
R Deane et al.
NEURON (2004)
All three LDL receptor homology regions of the LDL receptor-related protein bind multiple ligands
JE Croy et al.
BIOCHEMISTRY (2003)
RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain
R Deane et al.
NATURE MEDICINE (2003)
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis
R Kayed et al.
SCIENCE (2003)
Efflux of human and mouse amyloid beta proteins 1-40 and 1-42 from brain: Impairment in a mouse model of Alzheimer's disease
WA Banks et al.
NEUROSCIENCE (2003)
Blood-brain barrier permeability precedes senile plaque formation in an Alzheimer disease model
M Ujiie et al.
MICROCIRCULATION (2003)
Cerebral hemorrhage after passive anti-Aβ immunotherapy
M Pfeifer et al.
SCIENCE (2002)
Human antibodies against amyloid β peptide:: A potential treatment for Alzheimer's disease
R Dodel et al.
ANNALS OF NEUROLOGY (2002)
Circulating amyloid-β peptide crosses the blood-brain barrier in aged monkeys and contributes to Alzheimer's disease lesions
JB Mackic et al.
VASCULAR PHARMACOLOGY (2002)
Brain to plasma amyloid-β efflux:: a measure of brain amyloid burden in a mouse model of Alzheimer's disease
RB DeMattos et al.
SCIENCE (2002)
The α-chains of C4b-binding protein mediate complex formation with low density lipoprotein receptor-related protein
E Westein et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Reduced levels of amyloid β-peptide antibody in Alzheimer disease
Y Du et al.
NEUROLOGY (2001)
Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's disease
RB DeMattos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Clearance of Alzheimer's amyloid-β1-40 peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier
M Shibata et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Specific binding of α-macroglobulin to complement-type repeat CR4 of the low-density lipoprotein receptor-related protein
OM Andersen et al.
BIOCHEMISTRY (2000)
分享论文
